1. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial;N Engl J Med,1989
2. GISSI-2. A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990
3. Adoption of thrombolytic therapy in the management of acute myocardial infarction;Hlatky;Am J Cardiol,1988
4. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction;Lancet,1986
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 19XX;ii:349–360.